SCHEMBL7252437

SCHEMBL7252437

Cc1ccc(-c2ccc(CNC(=O)Oc3cc(NC(=O)c4ccccc4Oc4ccccc4)cn3C)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.46
GAA P10253 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HTT P42858 1/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPK14 Q16539 1/20 0.43
AKR1C3 P42330 3/20 0.42
AKR1C2 P52895 1/20 0.42
TP53 P04637 2/20 0.41
GLA P06280 1/20 0.41
TSHR P16473 1/20 0.41
HDAC1 Q13547 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
BRD4 O60885 1/20 0.40
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7041358 0.87 ALDH1A1 (0.51) HPGDGAAALDH1A1HTTATM
SCHEMBL6675775 0.87 CHRNB2 (0.44) HPGDALDH1A1HTTL3MBTL1MEN1
SCHEMBL7252308 0.85 ALDH1A1 (0.58) HPGDALDH1A1HTTL3MBTL1MEN1
SCHEMBL6675696 0.84 LMNA (0.43) ALDH1A1HTTL3MBTL1KMT2AAKR1C3
SCHEMBL6680330 0.81 MTTP (0.49) KDM4E
SCHEMBL6674202 0.80 ALDH1A1 (0.47) HPGDGAAALDH1A1HTTL3MBTL1
SCHEMBL6674613 0.78 MAPT (0.41) HPGDGAAALDH1A1L3MBTL1KMT2A
SCHEMBL7252903 0.74 MTTP (0.50)
SCHEMBL6674719 0.74 MTTP (0.49)
SCHEMBL6675663 0.73 MTTP (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003004020-A1 HETEROARYL CARBOXYLIC ACID AMIDES, THE PRODUCTION THEREOF AND THE USE OF THE SAME AS INHIBITORS OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-01-16 WO disclosed